A new GS1 Healthcare report on the progress made in meeting the serialization requirements of the Drug Supply Chain Security Act (DSCSA) found significant progress, especially in comparison to reports from 2017 and 2018. Part of the reason for the progress can be attributed to a US Food and Drug Administration (FDA)  deadline extension  to November 2018 for certain product identifiers. “Of course, the compliance deadline really drove suppliers’ actions toward seria...